Theora

Theora is a Y Combinator-backed company that openEvidence for Pharmaceutical Evidence. Based in San Francisco, USA, the company participated in the Summer 2025 batch of Y Combinator.

Ensuring every approved drug reaches patients who need it.

Auditable AI to satisfy regulators and payors 10x faster. We Synthesize fragmented pharma and device data to prove safety, optimize market access, and anticipate regulatory response.

Members of our team worked in software engineering at Apple and AI at NVIDIA, helped start a large-cap pharma clinical trial, and trained at Harvard Medical School.

Theora was part of Y Combinator's Summer 2025 cohort, has a team of approximately 3 employees, and is actively operating.